Boston Scientific (NYSE:BSX) today unveiled new results from a clinical trial of its Watchman stroke prevention device, reporting that the cardiac implant met 2 of 3 co-primary endpoints for safety and effectiveness compared with drug therapy.
MASSDEVICE ON CALL — Pharmaceutical management services giant Express Scripts Holding Co. sued accounting firm Ernst & Young, claiming that an E&Y employee sneaked into Express Scripts offices to steal trade secrets.
Express Scripts fingered Don Gravlin, a partner at E&Y, for the alleged misconduct, saying Gravlin and the company "were possessed with an evil motive" in stealing more than 20,000 pages of pricing information, projections and other confidential data, according to the legal complaint.
MASSDEVICE ON CALL — The number of cardiologists practicing in the U.S. has tripled since 2007, according to an American College of Cardiology census of more than 2,500 cardiologists.
That’s a sign that the trend toward hospital integration is proceeding apace, according to heartwire.
Only 60% of cardiology practices are doctor-owned, compared with 72% 5 years ago, and 24% are hospital owned – a drastic rise compared with 8% in 2007.
MASSDEVICE ON CALL — A German team developed a new hip replacement implant that may be the answer to the high-profile hip device debates following the recall of DePuy’s metal-on-metal implants.
The researchers announced new hip implants that "unlike the conventional counterpart implants on the market today, provide a metal-free solution and bone-like elasticity."
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.